Type 1 1/2 Diabetes: Myth or Reality?

References

• Boissier De Sauvages F. Nosologia Methodica. Nosologia Methodica, F. B.D. Sauvages. De Tournes Brothers, Amsterdam 1763; Vol. 3: 184–188, Part 2
   Google Scholar
• Levine R. Historical view of the classifications of diabetes. Clin. Chem. 1986; 32: B4–B6
   Web of Science ®Google Scholar
• Himsworth H. Diabetes Mellitus: Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1936; i: 127–130
   Google Scholar
• Lampeter E. F., Homberg M., Quabeck K., Schaefer U. W., Wernet P., Bertrams J., et al. Transfer of insulindependent diabetes between HLA-identical siblings by bone marrow transplantation [see comments]. Lancet 1993; 341: 1243–1244
   PubMed Web of Science ®Google Scholar
• Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group. Diabetes 1988; 37: 1574–1582
   PubMed Web of Science ®Google Scholar
• DeFronzo R. A. Palhogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 1992; 35: 389–397
   PubMed Web of Science ®Google Scholar
• Porte D. Jr. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 1991; 40: 166–180
   PubMed Web of Science ®Google Scholar
• Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation [see comments]?. Diabetes 1994; 43: 613–621
   PubMed Web of Science ®Google Scholar
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28: 1039–1057
   PubMed Web of Science ®Google Scholar
• Diabetes Mellitus: Report of a WHO study group. World Health Organization Technical Report Series 1985; 727: 1–113
   PubMedGoogle Scholar
• Tuomi T., Groop L., Zimmet P., Rowley M., Knowles W., Mackay I. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dcpendent onset of disease. Diabetes 1993; 42: 359–362
   PubMed Web of Science ®Google Scholar
• Zimmet P., Tuomi T., Mackay I., Rowley M., Knowles W., Cohen M., et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diab. Med. 1994; 11: 299–303
   PubMed Web of Science ®Google Scholar
• Kobayashi T. Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM-the clinical characteristics and pathogenesis of the syndrome. Diabetes Res. Clin. Prac 1994; 24: S96–S99
   Web of Science ®Google Scholar
• Kobayashi T., Tamemoto K., Nakanishi K., Kato N., Okubo M., Kajio H., et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993; 16: 780–788
   PubMed Web of Science ®Google Scholar
• Groop L., Bottazzo G. F., Doniach D. Islet cell antibodies identify latent Type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes 1986; 35: 237–241
   PubMed Web of Science ®Google Scholar
• Editorial. Insulin-dependent?. Lancet 1985; 2: 809–810
   PubMed Web of Science ®Google Scholar
• Harris M., Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus, K. Alberti, R. DeFronzo, H. Keen, P. Zimmet. John Wiley & Sons Ltd. 1992; 3–18
   Google Scholar
• Kasuga A., Maruyama T., Ozawa Y., Takei L., Falorni A., Lernmark A., et al. Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese. J. Autoimmun. 1996; 9: 105–111
   PubMed Web of Science ®Google Scholar
• Zimmet P. The pathogenesis and prevention of diabetes in adults. Diabetes Care 1995; 18: 1050–1064
   PubMed Web of Science ®Google Scholar
• Landin O.-M., Nilsson K. O., Lernmark A., Sundkvist G. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 1990; 33: 561–568
   PubMed Web of Science ®Google Scholar
• Gottsater A., Landin-Olsson M., Lernmark A., Frenlund P., Sundkvist G. Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients. Acta Diabetol. 1994; 31: 226–231
   PubMed Web of Science ®Google Scholar
• Gleichmann H., Zorcher B., Greulich B., Gries F., Henrichs H., Bertrams J., et al. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 1984; 27: 90–92
   PubMed Web of Science ®Google Scholar
• Groop L., Miettinen A., Groop P., Meri S., Koskimies S., Bottazzo G. Organ-specific autoimmunity and HL-DR antigens as markers for B-cell destruction in patients with Type II diabetes. Diabetes 1988; 37: 99–103
   PubMed Web of Science ®Google Scholar
• Di M.-U., Irvine W. J., Borsey D. Q., Kyner J. L., Weston J., Galfo C. Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 1983; 25: 392–395
   PubMed Web of Science ®Google Scholar
• Irvine W. J., Sawers J. S., Feek C. M., Prescott R. J., Duncan L. J. The value of islet cell antibody in predicting secondary failure of oral hypoglycaemic agent therapy in diabetes mellitus. J. Clin. Lab. Immunol. 1979; 2: 23–26
   PubMedGoogle Scholar
• Kobayashi T., Nakanishi K., Sugimoto T., Itoh T., Murase T., Kosaka K., et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care 1989; 12: 7–11
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Itoh T., Kosaka K., Sato K., Tsuji K. Time course of islet cell antibodies and beta-cell function in non-insulin dependent stage of Type 1 diabetes. Diabetes 1987; 36: 510–517
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Sugimoto T., Murase T., Itoh T., Kosaka K. Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin dependent diabetics. Diabetes Res. 1988; 9: 105–109
   PubMedGoogle Scholar
• Winter W., MacLaren N., Riley W., Clarke D., Kappy M., Spillar R. Maturity-onset diabetes of youth in Black Americans. N. Engl. J. Med. 1987; 316: 285–291
   PubMed Web of Science ®Google Scholar
• Banerji M., Chaiken R., Huey H., Tuomi T., Norin A., Mackay I., et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush Diabetes. Diabetes 1994; 43: 741–745
   PubMed Web of Science ®Google Scholar
• Harris M., Robbins D. Prevalence of adult-onset IDDM in the US population. Diabetes Care 1994; 17: 1337–1340
   PubMed Web of Science ®Google Scholar
• Maislos M., Bodner-Fishman B., Weilzman S. Prevalence and clinical characteristics of Type I and Type 11 insulin-treated diabetes in the community. Diabetes Care 1994; 17: 1230–1231
   PubMed Web of Science ®Google Scholar
• Maislos M., Weitzman S. Prevalence of IDDM in adults in the community. Diabetes Care 1995; 18: 885–886
   PubMed Web of Science ®Google Scholar
• Morrison E. A., Rosenbloom A., McLaren N., Riley W., Kooperman S. Absence of islet cell antibodies in Jamaican Blacks with diabetes mellitus. West Indian Med. J. 1986; 35: 35–37
   PubMed Web of Science ®Google Scholar
• McLarty D., Athaide I., Bottazzo G., Swai A., Alberti K. Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. Diabetes Res. Clin. Pract. 1990; 9: 219–224
   PubMed Web of Science ®Google Scholar
• Tuomi T., Zimmet P., Rowley M., Min H., Vichayanrat A., Lee H., et al. Differing frequency of autoantibodics to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clin. Immunol. Immunopathol. 1995; 74: 202–206
   PubMedGoogle Scholar
• Zimmet P., Rowley M., Mackay I., Knowles W., Chen Q., Chapman L., et al. The ethnic distribution of antibodies to glutamic acid decarboxylase: Presence and levels in insulin-dependent diabetes mellitus in Europid and Asian subjects. J. Diabetie Complications 1993; 7: 1–7
   Google Scholar
• Knowler W., Bennett P., Bottazzo G., Doniach D. Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 1979; 17: 161–164
   PubMed Web of Science ®Google Scholar
• Dowse G., Zimmet P., Spark R., Mavo B., Rowley M., Mackay I. Lack of antibodies to glutamic acid decarboxylase in young adults of the high diabetes prevalence Wanigela people of Papua New Guinea. Diabetes Res. Clinic. Pract. 1994; 24: 195–198
   PubMed Web of Science ®Google Scholar
• Bakos S., Mackay I., Rowley M., Knowles W., Zimmet P. Islet cell antibodies and other markers of autoimmunity and diabetes mellitus in Nauruans. Diabetologia 1991; 34: 796–800
   PubMedGoogle Scholar
• Diabetes Statistics. Diabetes 1996: Vital Statistics, C. Cowie, M. Eberhardt. American Diabetes Association. 1996; 13–20
   Google Scholar
• Karjalaincn J., Salmela P., Llonen J., Surccl H. M., Knip M. A comparison of childhood and adult type I diabetes mellitus. N. Engl. J. Med. 1989; 320: 881–886
   PubMed Web of Science ®Google Scholar
• Lorenzen T., Pociot F., Hougaard P., Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994; 37: 321–327
   PubMed Web of Science ®Google Scholar
• Hagopian W., Karlsen A., Gottsater A., Landin-Olsson M., Grubin C., Sundkvist G., et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 1993; 91: 368–374
   PubMed Web of Science ®Google Scholar
• Rowley M., Mackay I., Chen Q., Knowles W., Zimmet P. Antibodies to glutamic acid decarboxylase descriminatc major types of diabetes mellitus. Diabetes 1992; 41: 548–551
   PubMed Web of Science ®Google Scholar
• Seubert M., de Sonnaville J., Moser L., Seissler J., Heine R. Prevalence and predictive value of GAD-antibodies in diabetes mellitus diagnosed above 40 years of age. Diabetologia 1996; 39: A91
   PubMed Web of Science ®Google Scholar
• Scott R., Willis J., Brown L., Forbes R., Sehmidli R., Zimmet P., et al. Antibodies to glutamic acid decarboxylase (GAD) predict insulin-deficiency in adult onset diabetes mellitus. Diabetes 1993; 42: 220A
   Web of Science ®Google Scholar
• Zimmet P., Shaten B., Kuller L., Rowley M., Knowles W., Mackay I. Antibodies to glutamic acid decarboxylase and diabetes mellitus in the multiple risk factor intervention trial. Am. J. Epidemiol. 1994; 140: 683–690
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Karlsson F., Lernmark A., Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992; 41: 1022–1027
   PubMed Web of Science ®Google Scholar
• Orchard T. From diagnosis and classification to complications and therapy: DCCT Part II?. Diabetes Care 1994; 17: 326–338
   PubMed Web of Science ®Google Scholar
• Molbak A., Christau B., Marner B., Borch-Johnsen K., Nerup J. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabet. Med. 1994; 11: 650–655
   PubMed Web of Science ®Google Scholar
• Hagopian W., Sanjeevi C., Kockum L, Landin-Olsson M., Karlsen A., Sundkvist G., et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 1995; 95: 1505–1511
   PubMed Web of Science ®Google Scholar
• Verge C., Gianaini R., Kawasaki E., Yu L., Pietropaolo M., Chase H., et al. Number of autoantibodies (against insulin, GAD or ICA512/1A2) rather than particular autoantibody specificities determines risk of Type 1 diabetes. J Autoimmun. 1996; 9: 379–383
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Palmer J., Lernmark A., Blom L., Sundkvist G., Nystrom L., et al. Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068–1073
   PubMed Web of Science ®Google Scholar
• Verge C., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R., et al. Prediction of Type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA 512bcd/IA-2 autoantibodies. Diabetes 1996; 45: 926–933
   PubMed Web of Science ®Google Scholar
• Willis J., Scott R., Brown L., Forbes L., Sehmidli R., Zimmet P., et al. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. Diabetes Res. Clin. Pract. 1996; 33: 89–97
   PubMed Web of Science ®Google Scholar
• Lamberton P., Jackson I. Thyroiditis. Principles and Practice of Endocrinology and Metabolism, K. Becker. J.B. Lippincoll Company, Philadelphia 1995; 413–420
   Google Scholar
• Podolsky D., Isselbacher K. Alcohol-related liver disease and cirrhosis. Harrison's Principles of Internal Medicine, K. Isselbacher, E. Braunwald, J. Wilson, J. Martin, A. Fauci, D. Kasper. McGraw-Hill, Inc. 1994; Vol. 2: 1483–1495
   Google Scholar
• Schiffrin A., Suissa S., Poussier P., Guttmann R., Weitzner G. Prospective study of predictors of beta-cell survival in Type I diabetes. Diabetes 1988; 37: 920–925
   PubMed Web of Science ®Google Scholar
• Davies J. L., Kawaguchi Y., Bennett S. T., Copeman J. B., Cordell H. J., Pritchard L. E., et al. A genome-wide search for human type 1 diabetes susceptibility genes [see comments]. Nature 1994; 371: 130–136
   PubMed Web of Science ®Google Scholar
• Khalil I., d'Auriol L., Gobet M., Morin L., Lepage V., Deschamps I., et al. A combination of HLA DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J. Clin. Invest. 1990; 85: 1315–1319
   PubMed Web of Science ®Google Scholar
• Nepom G. T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990; 39: 1153–1157
   PubMed Web of Science ®Google Scholar
• Caillat Z.-S., Garchon H. J., Timsit J., Assan R., Boitard C., Djilali S.-I., et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J. Clin. invest. 1992; 90: 2242–2250
   PubMed Web of Science ®Google Scholar
• Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 1987; 40: 1–14
   PubMed Web of Science ®Google Scholar
• Bell G. I., Horita S., Karam J. H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176–183
   PubMed Web of Science ®Google Scholar
• Junien C., Van H.-V. Report of the committee on the genetic constitution of chromosome 11. Cytogenet. Cell Genet. 1990; 55: 153–169
   PubMedGoogle Scholar
• Lucassen A. M., Julier C., Beressi J. P., Boitard C., Froguel P., Lathrop M., et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet. 1993; 4: 305–310
   PubMed Web of Science ®Google Scholar
• Bennett St., Lucassen A. M., Gough S. C., Powell E. E., Undlien D. E., Pritchard L. E., et al. Susceptibility to human type 1 diabetes at 1DDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus [see comments]. Nat. Genet. 1995; 9: 284–292
   PubMed Web of Science ®Google Scholar
• Pugliese A., Awdeh Z. L., Alper C. A., Jackson R. A., Eisenbarth G. S. The paternally inherited insulin gene B allele (1,428 Fokl site) confers protection from insulin-dependent diabetes in families. J. Autoimmun. 1994; 7: 687–694
   PubMed Web of Science ®Google Scholar
• Bennett S. T., Wilson A. J., Cucca F., Nerup J., Pociot F., McKinney P. A., et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J. Autoimmun. 1996; 9: 415–421
   PubMed Web of Science ®Google Scholar
• Vafiadis P., Bennett St., Colle E., Grabs R., Goodyer C. G., Polychronakos C. Imprinted and genotypespecific expression of genes at the IDDM2 locus in pancreas and leucocytes. J. Autoimmun. 1996; 9: 397–403
   PubMed Web of Science ®Google Scholar
• Vafiadis P., Bennett S., Todd J., Nadeau J., Grabs R., Goodyer C., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the 1DDM2 locus. Nat. Genet. 1997; 15: 289–292
   PubMed Web of Science ®Google Scholar
• Puglcise A., Zeller M., Fernandez A. J., Zalcberg L., Bartlett R., Ricordi C., et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allclic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 1997; 15: 293–297
   PubMed Web of Science ®Google Scholar
• Juneja R., Brooks-Worrell B., Schranz D., Greenbaum C., Palmer J. Islet antibody clustering and peripheral blood mononuclear cell response to human islet antigens in antibody positive NIDDM patients. Diabetes 1997; 46(Suppl. 1)347A
   Google Scholar
• Taylor S. I. The hunt for mutations causing noninsulindependent diabetes mellitus [editorial]. J. Clin. Endocrinol. Metab. 1992; 75: 1401–1403
   PubMed Web of Science ®Google Scholar
• Hanis C. L., Bocrwinkle E., Chakraborty R., Ellsworth D. L., Concannon P., Stirling B., et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 1996; 13: 161–166
   PubMed Web of Science ®Google Scholar
• Mahtani M. M., Wid'en E., Lehto M., Thomas J., McCarthy M., Brayer J., et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat. Genet. 1996; 14: 90–94
   PubMed Web of Science ®Google Scholar
• Stone L. M., Kahn S. E., Fujimoto W. Y., Deeb S. S., Porte D. Jr. A variation at position-30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Diabetes 1996; 45: 422–428
   PubMed Web of Science ®Google Scholar
• Ostman J., Arnqvist H., Blohm'e G., Lithner F., Littorin B., Nystrom L., et al. Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15–34 years. Acta Med. Scand. 1986; 220: 437–445
   PubMedGoogle Scholar
• Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulindependent diabetes mellitus. Nature 1987; 329: 599–604
   PubMed Web of Science ®Google Scholar
• Yamagata K., Nakajima H., Hanafusa T., Noguchi T., Miyazaki A., Miyagawa J., et al. Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1989; 32: 762–764
   PubMed Web of Science ®Google Scholar
• Maruyama T., Shimada A., Kasuga A., Kasatani T., Ozawa Y., Ishii M., et al. Analysis of MHC Class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay. Diabetes Res. Clin. Pract. 1994; 23: 77–84
   PubMed Web of Science ®Google Scholar
• Kosaka K., Kuzuya T., Akanuma Y., Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 1980; 18: 23–28
   PubMed Web of Science ®Google Scholar
• Oka Y. NIDDM genetic marker; glucose transporter, glucokinase, and mitochondria gene. Diabetes Res. Clin. Pract. 1994, 24 Suppl: S117–S121
   Google Scholar
• Ballinger S. W., Shoffner J. M., Hedaya E. V., Trounce I., Polak M. A., Koontz D. A., et al. Maternally transmitted diabetes and deafness associated with a 10.4kb mitochondrial DNA deletion. Nut. Genet. 1992; 1: 11–15
   PubMed Web of Science ®Google Scholar
• Van D.-O.-J. M., Lemkes H. H., Ruitenbeek W., Sandkuijl L. A., De V.-M. F., Struyvcnberg P. A., et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1992; 1: 368–371
   PubMed Web of Science ®Google Scholar
• Reardon W., Ross R. J., Sweeney M. G., Luxon L. M., Pembrey M. E., Harding A. E., et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA [see comments]. Lancet 1992; 340: 1376–1379
   PubMed Web of Science ®Google Scholar
• Katagiri H., Asano T., Yamanouchi T., Yazaki Y., Oka Y. Glucokinase-defective NIDDM [letter; comment]. Lancet 1993; 341: 961–962
   PubMed Web of Science ®Google Scholar
• Kadowaki H., Tobe K., Mori Y., Sakura H., Sakuta R., Nonaka I., et al. Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus [letter]. Lancet 1993; 341: 893–894
   PubMed Web of Science ®Google Scholar
• Oka Y., Katagiri H., Yazaki Y., Murase T., Kobayashi T. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 1993; 342: 527–528
   PubMed Web of Science ®Google Scholar
• Oka Y., Katagiri H., Ishihara H., Asano T., Kikuchi M., Kobayashi T. Mitochondrial diabetes mellitus-glucose-induced signaling defects and beta-cell loss. Muscle Nerve 1995; 3: S131–S136
   Google Scholar
• Sener A., Malaisse W. J. Stimulation by D-glucose of mitochondrial oxidative events in islet cells. Biochem. J. 1987; 246: 89–95
   PubMed Web of Science ®Google Scholar
• Niskanen L., Karjalainen J., Siitonen O., Uusitupa M. Metabolic evolution of type 2 diabetes: a 10-year follow-up from the time of diagnosis. J. Intern. Med. 1994; 236: 263–270
   PubMed Web of Science ®Google Scholar
• Gray R. S., Irvine W. J., Cameron E. H., Duncan L. J. Glucose and insulin responses to oral glucose in overt non-insulin-dependent diabetics with and without the islet cell antibody. Diabetes 1980; 29: 312–316
   PubMed Web of Science ®Google Scholar
• Niskanen L., Karjalainen J., Sarlund H., Siitonen O., Uusitupa M. Five-year follow-up of islet cell antibodies in type 2 (non-insulin-dependent) diabetes mellilus. Diabetologia 1991; 34: 402–408
   PubMedGoogle Scholar
• Irvine W. J., McCallum C. J., Gray R. S., Duncan L. J. Clinical and pathogenic significance of pancreaticislet-cell antibodies in diabetics treated with oral hypoglycaemic agents. Lancet 1977; 1: 1025–1027
   PubMed Web of Science ®Google Scholar
• Gottsater A., Landin O.-M., Fernlund P., Lernmark A., Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 1993; 16: 902–910
   PubMed Web of Science ®Google Scholar
• Del P.-G. F., Betterle C., Padovan D., Erie G., Toffolo A., Bersahi G. Incidence and significance of islet-cell auloantibodies in different types of diabetes mellitus. Diabetes 1977; 26: 909–915
   PubMed Web of Science ®Google Scholar
• Jennings A. M., Spencer K. M., Dean B. M., Wilson R. M., Bottazzo G. F., Ward J. D. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents. Diabet. Med. 1989; 6: 434–439
   PubMed Web of Science ®Google Scholar
• Gotfredsen C., Buschard K., Frandsen E. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933–935
   PubMed Web of Science ®Google Scholar
• Atkinson M., Maclaren N., Luchetta R., Burr I. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39: 933–937
   PubMed Web of Science ®Google Scholar
• Keller R. J., Eisenbarth G. S., Jackson R. A. Insulin prophylaxis in individuals at high risk of type I diabetes [see comment]. Lancet 1993; 341: 927–928
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Nakanishi K., Murase T., Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45: 622–626
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Miyashita H., Ohkubo M., Sugimoto T., Murase T., et al. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radio-immunoassay. Metabolism 1990; 39: 925–930
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Inoko H., Tsuji K., Murase T., Kosaka K. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes 1995; 44: 1334–1339
   PubMed Web of Science ®Google Scholar
• Sjoberg S., Gunnarsson R., Gjotterberg M., Lefvert A. K., Persson A., Ostman J. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type I (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 208–213
   PubMed Web of Science ®Google Scholar
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [see comments]. N. Engl. J. Med. 1993; 329: 977–986
   PubMed Web of Science ®Google Scholar
• Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 1992; 8: 179–208
   PubMed Web of Science ®Google Scholar
• Barnett M., Collier G., Zimmet P., O'Dea K. The effect of restricting energy intake on diabetes in Psammomys Obesus. Int. J. Obesity 1994; 18: 789–794
   Web of Science ®Google Scholar
• Duhault J., Boulanger M., Espinal J., Marquie G., Petkov P., du Boistesselin R. Latent autoimmune diabetes mellitus in adult humans with non-insulin dependent diabetes: is Psammomys obesus a suitable animal model?. Acta Diabetol. 1995; 32: 92–94
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Miyashita H., Okubo M., Sugimoto T., Murase T., et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am. J. Gastroenterol. 1994; 89: 762–766
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Miyashita H., Okubo M., Sugimoto T., Murase T., et al. Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 1993; 42: 196–203
   PubMed Web of Science ®Google Scholar
• Nakanishi K., Kobayashi T., Sugimoto T., Murase T., Itoh T., Kosaka K. Does pan-pancreatic involvement occur in IDDM [letter]?. Diabetes Care 1988; 11: 100–101
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Nakanishi K., Kajio H., Morinaga S., Sugimoto T., Murase T., et al. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 363–370
   PubMed Web of Science ®Google Scholar
• Landin O.-M., Borgstrom A., Blom L., Sundkvist G., Lernmark A. Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. The Swedish Childhood Diabetes Group. Pancreas 1990; 5: 241–247
   PubMed Web of Science ®Google Scholar
• Bhatia E., Baijal S. S., Kumar K. R., Choudhuri G. Exocrine pancreatic and beta-cell function in malnutrition-related diabetes among north Indians. Diabetes Care 1995; 18: 1174–1178
   PubMed Web of Science ®Google Scholar
• Mohan V., Snehalatha C., Ahmed M. R., Madanagopalan N., Chari S., Jayanthi V., et al. Exocrine pancreatic function in tropical fibrocalculous pancreaticdiabetes. Diabetes Care 1989; 12: 145–147
   PubMed Web of Science ®Google Scholar
• Yajnik C. S., Sahasrabudhe R. A., Naik S. S., Katrak A., Shelgikar K. M., Kanitkar S. V., et al. Exocrine pancreatic-function (serum immunoreactive trypsin, fecal chymotrypsin, and pancreatic isoamylase) in Indian diabetics. Pancreas 1990; 5: 631–638
   PubMed Web of Science ®Google Scholar
• Yajnik C. S., Shelgikar K. M., Sahasrabudhe R. A., Naik S. S., Pai V. R., Alberti K. G., et al. The spectrum of pancreatic exocrine and endocrine (beta-cell) function in tropical calcific pancreatitis. Diabetologia 1990; 33: 417–421
   PubMed Web of Science ®Google Scholar
• Vannasaeng S., Nitiyanant W., Vichayanrat A., Ploybutr S., Harnthong S. C-peptide secretion in calcific tropical pancreatic diabetes. Metabolism 1986; 35: 814–817
   PubMed Web of Science ®Google Scholar
• Rao R. H. Diabetes in the undernourished: coincidence or consequence?. Endocr. Rev. 1988; 9: 67–87
   PubMed Web of Science ®Google Scholar
• Hugh-Jones P. Diabetes in Jamaica. Lancet 1955; ii: 891–897
   Google Scholar
• Tripathy B. B., Kar B. C. Observations on the clinical patterns of diabetes mellitus in India. Diabetes 1965; 14: 404–412
   PubMed Web of Science ®Google Scholar
• Ahuja M. M.S., Talwar G. P., Varma V. M., Kumar A. Diabetes mellitus in young Indians. Indian J. Med. Res. 1965; 53: 1138–1147
   Web of Science ®Google Scholar
• Patel M. S., Colman P. G., Martin F. I., Sengupta S. K. Fibrocalculous pancreatic diabetes in Papua New Guinea. Diabetes Res. 1988; 7: 97–101
   PubMedGoogle Scholar
• Sanjeevi C. B., Kanungo A., Samal K. C., Tripathy B. B., Lernmark A., Falorni A. GAD65 antibodies in insulin-dependent diabetes (IDDM), malnutrition-related diabetes (MRDM) and non-insulin dependent diabetes (NIDDM) patients from eastern India. Diabetologia 1996; 39: A81
   Google Scholar
• Huh K. B., Lee H. C., Kim H. M., Cho Y. W., Kim Y. L., Lee K. W., et al. Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea. Diabetes. Res. Clin. Pract. 1992; 16: 63–70
   PubMed Web of Science ®Google Scholar
• Hartini S., Kariadi K. S., Taniguchi H. Re: ICA in MRDM (FCPD) [letter]. Diabetes Res. Clin. Pract. 1989; 7: 159
   PubMedGoogle Scholar
• Mohan V., Ramachandran A., Viswanathan M. Low prevalence of ICA in MRDM [letter]. Diabetes Res. Clin. Pract. 1989; 6: 79–81
   PubMedGoogle Scholar
• Wiyono P., Morimoto Y., Taniguchi H. The presence of islet cell antibodies in malnutrition-related diabetes mellitus. Diabetes Res. Clin. Pract. 1989; 6: 75–78
   PubMed Web of Science ®Google Scholar
• Tandhanand B.-N., Kespichayawatana W., Vannasaeng S., Banchuin C., Laohapand T., Panpimarnmas S., et al. Presence of autoimmunity to pancreatic antigens in a patient with fibrocalculous pancreatic diabetes. Diabetes Res. Clin. Pract. 1992; 18: 17–21
   PubMed Web of Science ®Google Scholar
• Sutjahjo A., Taniguchi H., Morimoto Y., Hendromartono, Baba S., Tjokroprawiro A. Re: absence of ICA in malnutrition-related diabetes mellitus [letter]. Diabetes Res. Clin. Pract. 1988; 4: 313–314
   PubMedGoogle Scholar
• Taniguchi H., Sutjahjo A., Morimoto Y., Hendromartono, Tjokroprawiro A., Baba S. Re: Low prevalence of ICA in MRDM [letter]. Diabetes Res. Clin. Pract. 1989; 6: 81
   Google Scholar
• Teuscher T., Baillod P., Rosman J. B., Teuscher A. Absence of diabetes in a rural West African population with a high carbohydrate/cassava diet. Lancet 1987; 1: 765–768
   PubMed Web of Science ®Google Scholar
• McMillan D. E., Geevarghese P. J. Dietary cyanide and tropical malnutrition diabetes. Diabetes Care 1979; 2: 202–208
   PubMedGoogle Scholar
• Velloso L. A., Winqvist O., Gustafsson J., Kampe O., Karlsson F. A. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Diabetologia 1994; 37: 61–69
   PubMed Web of Science ®Google Scholar
• Ahonen P., Myllarniemi S., Sipila I., Pcrheentupa J. Clinical variation of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N. Engl. J. Med. 1990; 322: 1829–1836
   PubMed Web of Science ®Google Scholar
• Palmer J. Predicting IDDM: Use of humoral immune markers. Diabetes Reviews 1993; 1: 104–115
   Google Scholar
• Karlsen A. E., Hagopian W. A., Petersen J. S., Boel E., Dyrberg T., Grubin C. E., et al. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes 1992; 41: 1355–1359
   PubMed Web of Science ®Google Scholar
• Tuomilehto J., Zimmet P., Mackay I. R., Koskela P., Vidgren G., Toivanen L., et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease [see comments]. Lancet 1994; 343: 1383–1385
   PubMed Web of Science ®Google Scholar
• Chen Q. Y., Rowley M. J., Byrne G. C., Jones T. W., Tuomi T., Knowles W. J., et al. Antibodies to glutamic acid decarboxylase in Australian children with insulindependent diabetes mellitus and their first-degree relatives. Pediatr. Res. 1993; 34: 785–790
   PubMed Web of Science ®Google Scholar
• Verge C. F., Howard N. J., Rowley M. J., Mackay I. R., Zimmet P. Z., Egan M., et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994; 37: 1113–1120
   PubMed Web of Science ®Google Scholar
• Lan M. S., Wasserfall C., Maclaren N. K., Notkins A. L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 1996; 93: 6367–6370
   PubMed Web of Science ®Google Scholar